These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2905005)

  • 1. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
    Eskinder H; Hillard CJ; Olinger GN; Christensen CW; Baker JE; Warltier DC; Gross GJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
    Ruffolo RR; Zeid RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):636-43. PubMed ID: 2867204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of alpha-1 vs. alpha-2 adrenoceptor-mediated responses in canine saphenous vein by nitroglycerin.
    Eskinder H; Gross GJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):515-21. PubMed ID: 3016240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
    Ohlstein EH; Horohonich S; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):233-9. PubMed ID: 2536428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein.
    Cooke JP; Rimele TJ; Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1985 Sep; 234(3):598-602. PubMed ID: 2863368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein.
    Flavahan NA; Rimele TJ; Cooke JP; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 Sep; 230(3):699-705. PubMed ID: 6088763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
    Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):131-8. PubMed ID: 3014111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Bromo cyclic guanosine monophosphate mimics the actions of nitroglycerin on alpha-adrenergic mechanisms in canine saphenous vein.
    Eskinder H; Gross GJ
    Pharmacology; 1987; 35(1):16-23. PubMed ID: 2819902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
    Shi AG; Kwan CY; Daniel EE
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1119-24. PubMed ID: 2550616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium pump stimulation by activation of two alpha adrenergic receptor subtypes in canine blood vessels.
    Navran SS; Adair SE; Jemelka SK; Seidel CL; Allen JC
    J Pharmacol Exp Ther; 1988 May; 245(2):608-13. PubMed ID: 2835477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):139-47. PubMed ID: 3014112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.
    MacLennan SJ; Luong LA; Jasper JR; To ZP; Eglen RM
    Br J Pharmacol; 1997 Aug; 121(8):1721-9. PubMed ID: 9283709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alpha 2-adrenoceptor occupancy and response for B-HT 933 in canine saphenous vein.
    Ruffolo RR; Zeid RL
    Eur J Pharmacol; 1985 May; 111(2):267-71. PubMed ID: 2862046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
    Eskinder H; Gross GJ
    Eur Heart J; 1988 Jan; 9 Suppl A():11-5. PubMed ID: 2900765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha adrenoceptor-mediated vasoconstriction in rat hindlimb: innervated alpha-2 adrenoceptors in the saphenous arterial bed.
    Medgett IC; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Jul; 246(1):249-54. PubMed ID: 2899164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
    Ruffolo RR; Yaden EL
    J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of alpha adrenoceptors on vascular smooth muscle: electrophysiological differentiation in canine saphenous vein.
    Matthews WD; McCafferty GP; Grous M
    J Pharmacol Exp Ther; 1984 Nov; 231(2):355-60. PubMed ID: 6149307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo analysis of adrenergic and serotoninergic constrictions of the rabbit saphenous vein.
    Vayssettes-Courchay C; Ragonnet C; Cordi AA; Verbeuren TJ
    Eur J Pharmacol; 2000 Nov; 408(3):277-88. PubMed ID: 11090645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.
    Ruffolo RR; Morgan EL; Messick K
    J Pharmacol Exp Ther; 1984 Sep; 230(3):587-94. PubMed ID: 6088757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.